G.E. Leighton

822 total citations
17 papers, 715 citations indexed

About

G.E. Leighton is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Nutrition and Dietetics. According to data from OpenAlex, G.E. Leighton has authored 17 papers receiving a total of 715 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cellular and Molecular Neuroscience, 13 papers in Molecular Biology and 4 papers in Nutrition and Dietetics. Recurrent topics in G.E. Leighton's work include Receptor Mechanisms and Signaling (10 papers), Neuropeptides and Animal Physiology (10 papers) and Pharmacological Receptor Mechanisms and Effects (5 papers). G.E. Leighton is often cited by papers focused on Receptor Mechanisms and Signaling (10 papers), Neuropeptides and Animal Physiology (10 papers) and Pharmacological Receptor Mechanisms and Effects (5 papers). G.E. Leighton collaborates with scholars based in United Kingdom, Austria and South Africa. G.E. Leighton's co-authors include Joel W. Hughes, R.G. Hill, Raquel E. Rodrı́guez, Graeme Hewson, Ken Meecham, David C. Rees, David C. Horwell, John C. Hunter, John A. Davies and Thomas Griesbacher and has published in prestigious journals such as Annals of the New York Academy of Sciences, British Journal of Pharmacology and European Journal of Pharmacology.

In The Last Decade

G.E. Leighton

17 papers receiving 687 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G.E. Leighton United Kingdom 12 494 357 276 129 58 17 715
V.R. Olgiati Italy 14 472 1.0× 276 0.8× 237 0.9× 109 0.8× 38 0.7× 29 841
Gricelda Hernandez United States 6 237 0.5× 292 0.8× 490 1.8× 75 0.6× 82 1.4× 8 896
S. Franchi‐Micheli Italy 14 184 0.4× 231 0.6× 139 0.5× 46 0.4× 41 0.7× 39 557
J.C. Yeats United Kingdom 6 328 0.7× 386 1.1× 467 1.7× 130 1.0× 74 1.3× 11 1.0k
K. Ramabadran United States 16 461 0.9× 310 0.9× 394 1.4× 29 0.2× 92 1.6× 49 820
George A. Matwyshyn United States 17 474 1.0× 335 0.9× 315 1.1× 39 0.3× 62 1.1× 43 710
Kirti Shah Switzerland 5 242 0.5× 292 0.8× 417 1.5× 73 0.6× 66 1.1× 8 852
K. Gyires Hungary 15 214 0.4× 219 0.6× 177 0.6× 42 0.3× 102 1.8× 32 614
María Amelia Enero Argentina 14 428 0.9× 505 1.4× 218 0.8× 50 0.4× 63 1.1× 60 888
Herbert C. Wenger United States 10 225 0.5× 263 0.7× 130 0.5× 34 0.3× 42 0.7× 18 659

Countries citing papers authored by G.E. Leighton

Since Specialization
Citations

This map shows the geographic impact of G.E. Leighton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.E. Leighton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.E. Leighton more than expected).

Fields of papers citing papers by G.E. Leighton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G.E. Leighton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.E. Leighton. The network helps show where G.E. Leighton may publish in the future.

Co-authorship network of co-authors of G.E. Leighton

This figure shows the co-authorship network connecting the top 25 collaborators of G.E. Leighton. A scholar is included among the top collaborators of G.E. Leighton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G.E. Leighton. G.E. Leighton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Crome, Peter, F. O. Müller, G. Groenewoud, et al.. (1993). Single Dose and Steady-State Pharmacokinetic Profiles of Nifedipine GITS Tablets in Healthy Elderly and Young Volunteers. Clinical Drug Investigation. 5(4). 193–199. 16 indexed citations
2.
Hunter, John C., G.E. Leighton, Ken Meecham, et al.. (1990). CI‐977, a novel and selective agonist for the κ‐opioid receptor. British Journal of Pharmacology. 101(1). 183–189. 125 indexed citations
3.
Soar, Jasmeet, Graeme Hewson, G.E. Leighton, R.G. Hill, & Joel W. Hughes. (1989). L364,718 antagonizes the cholecystokinin-induced suppression of locomotor activity. Pharmacology Biochemistry and Behavior. 33(3). 637–640. 20 indexed citations
4.
Hewson, Graeme, G.E. Leighton, Reginald Hill, & Joel W. Hughes. (1989). Which Subtype(s) of 5‐HT Receptor Mediates the Anorectic Effects of Drugs That Act via the 5‐HT System?. Annals of the New York Academy of Sciences. 575(1). 525–528. 2 indexed citations
5.
Leighton, G.E., et al.. (1989). Antagonism of central and peripheral anoretic effects of caerulein by L-364,718. European Journal of Pharmacology. 161(2-3). 255–258. 8 indexed citations
6.
Griesbacher, Thomas, G.E. Leighton, R.G. Hill, & Joel W. Hughes. (1989). Reduction of food intake by central administration of cholecystokinin octapeptide in the rat is dependent upon inhibition of brain peptidases. British Journal of Pharmacology. 96(1). 236–242. 15 indexed citations
7.
Leighton, G.E., Raquel E. Rodrı́guez, R.G. Hill, & Joel W. Hughes. (1988). κ‐Opioid agonists produce antinociception after i.v. and i.c.v. but not intrathecal administration in the rat. British Journal of Pharmacology. 93(3). 553–560. 185 indexed citations
8.
Hewson, Graeme, et al.. (1988). Ketanserin antagonises the anorectic effect of DL-fenfluramine in the rat. European Journal of Pharmacology. 145(2). 227–230. 30 indexed citations
9.
Hewson, Graeme, G.E. Leighton, R.G. Hill, & Joel W. Hughes. (1988). The cholecystokinin receptor antagonist L364,718 increases food intake in the rat by attenuation of the action of endogenous cholecystokinin. British Journal of Pharmacology. 93(1). 79–84. 131 indexed citations
10.
Leighton, G.E., R.G. Hill, & Joel W. Hughes. (1988). Intrathecal injection of a ϰ opioid agonist produces hyperalgesia in the guinea pig. European Journal of Pharmacology. 157(2-3). 241–242. 13 indexed citations
11.
Leighton, G.E., Reginald Hill, & Joel W. Hughes. (1988). The effects of the kappa agonist PD-117302 on feeding behaviour in obese and lean Zucker rats. Pharmacology Biochemistry and Behavior. 31(2). 425–429. 6 indexed citations
12.
Hewson, Graeme, G.E. Leighton, R.G. Hill, & Joel W. Hughes. (1988). Quipazine reduces food intake in the rat by activation of 5‐HT2‐receptors. British Journal of Pharmacology. 95(2). 598–604. 21 indexed citations
13.
Leighton, G.E., et al.. (1988). A novel superfusion chamber for the measurement of endogenous glutamate release from cerebellar slices. Journal of Neuroscience Methods. 23(1). 57–61. 31 indexed citations
14.
Leighton, G.E., R.G. Hill, & Joel W. Hughes. (1988). Effects of 5-HT and alpha1 adrenoceptor antagonists on kappa opioid-induced sedation. Pharmacology Biochemistry and Behavior. 31(4). 899–904. 7 indexed citations
15.
Leighton, G.E., Reginald Hill, & Joel W. Hughes. (1988). A Comparison of the Effects of Bombesin Seen in the Isolated Ileum and Colon of the Guinea Pig. Annals of the New York Academy of Sciences. 547(1). 530–531. 1 indexed citations
16.
Leighton, G.E., et al.. (1987). Pharmacological profile of PD 117302, a selective κ‐opioid agonist. British Journal of Pharmacology. 92(4). 915–922. 75 indexed citations
17.
Rodrı́guez, Raquel E., G.E. Leighton, R.G. Hill, & Joel W. Hughes. (1986). In vivo evidence for spinal delta-opiate receptor-operated antinociception. Neuropeptides. 8(3). 221–241. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026